## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 2.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($286.67)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Chubb (CB) survey: 79% wealthy see growth as 74% still lack estate plans in 2025**
- Source: Stock Titan | 20251203T140000 | Somewhat-Bullish | Relevance: 100%
- Chubb's 2025 wealth survey, "The Resilient Mindset," reveals high optimism among affluent North Americans (79% expect economic growth), yet significant protection gaps exist. A striking 74% lack an estate plan and cyber risk is the top concern, despite only 41% having standalone cyber insurance. The survey also highlights trends in luxury spending, collectibles, and concerns about extreme weather and marine liability, emphasizing the generational wealth transfer complexities.

**2. VP Ortega Files To Sell 4,357 Of Chubb Ltd [CB]**
- Source: TradingView | 20251203T025403 | Somewhat-Bearish | Relevance: 100%
- Juan Luis Ortega, Vice President of Chubb Ltd (CB), filed a Form 144 with the SEC on December 2, 2025, indicating his intent to sell 4,357 shares of restricted securities. The proposed sale is scheduled for December 2, 2025, through Fidelity Brokerage Services. This filing is a mandatory step before an insider can sell restricted stock.

**3. Autonomous Research Adjusts Chubb Price Target to $319 From $310, Maintains Outperform Rating**
- Source: MarketScreener | 20251201T133800 | Bullish | Relevance: 100%
- Autonomous Research has increased its price target for Chubb to $319 from $310, while maintaining an Outperform rating on the stock. This adjustment reflects a positive outlook from the research firm regarding Chubb's performance. The article also mentions other recent analyst actions and company news for Chubb Limited.

**4. W.R. Berkley Corp. stock underperforms Monday when compared to competitors**
- Source: MSN | 20251203T220833 | Somewhat-Bearish | Relevance: 74%
- W.R. Berkley Corp. stock experienced an underperformance on Monday compared to its competitors. It closed at $89.05, which was 1.13% below its 52-week high, while the S&P 500 also saw a slight decline. The company's stock lagged behind major competitors like Chubb Ltd. and Travelers Cos. Inc.

**5. W.R. Berkley Corp. stock underperforms Monday when compared to competitors**
- Source: MSN | 20251203T225139 | Somewhat-Bullish | Relevance: 71%
- W.R. Berkley Corp. (WRB) stock experienced a drop of 1.48% on Monday, closing at $82.78, which underperformed the S&P 500's gain of 0.20%. This decline also put the company behind its competitors, including Chubb Ltd. (CB) and Travelers Cos. Inc. (TRV), which saw increases. The stock traded between $82.73 and $84.09 during the session, and its 52-week range is $67.58 to $87.89.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Morgan Stanley | $300 | $295 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($14.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.2% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $15M sold (7 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.26 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $125.0B |
| Beta | 0.52 |
| 52W Range | $252.16 - $314.68 |
| Short Interest | 0.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.26 |
| Forward P/E | 11.2 |
| Current P/E | 12.5 |
| YoY Growth | 11.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 1.8% to -1.4% (-3.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.56), momentum weakening. RSI neutral at 58. OFD pattern: +DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.42% (CS: 38) | Neutral |
| RSI_14 | 58.3 | Neutral |
| MACD Histogram | -0.56 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 1.042x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $295.05
- **Stop Loss:** $286.67 (2.8% risk)
- **Target:** $303.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $33,340.65
- **Portfolio %:** 33.34%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*